News
Public · Published
SEBI sets up panel to ease market access for startups, deep-tech firms
SEBI constituted an 18-member working group to review rules for India's Innovators Growth Platform, which helps startups and innovation-led companies access capital markets. The panel will examine listing eligibility, investor participation, fundraising rules, post-listing obligations, and how companies can move from the platform to the main board.
Published:
Updated:
What happened
SEBI constituted an 18-member working group to review rules for India’s Innovators Growth Platform, which helps startups and innovation-led companies access capital markets. The panel will examine listing eligibility, investor participation, fundraising rules, post-listing obligations, and how companies can move from the platform to the main board.
Confirmed
Global impact / market context
If SEBI changes eligibility or fundraising rules, more early-stage firms with long research periods and little initial revenue could find it easier to raise money publicly. That may broaden funding options, while changes to disclosure and governance rules could also affect companies’ compliance costs.
Analyst inference
The review spans both access to funding and safeguards after listing: pricing, allocation and minimum subscriptions shape fundraising, while disclosures and governance rules shape ongoing obligations. Its focus on sectors such as deep-tech and biotechnology reflects the financing challenges described for businesses with long development cycles.
Confirmed
What to watch
- SEBI’s working group is reviewing eligibility and listing requirements, investor participation rules, and public fundraising provisions, including offer-for-sale, pricing, allocation and minimum subscriptions. Confirmed
- The panel will examine post-listing disclosures, governance, trading and compliance, as well as requirements for moving IGP-listed companies to the main board. Confirmed
- Watch for any recommendations that lower entry barriers or alter investor protections; the article does not report final changes, so effects on fundraising and costs remain uncertain. Analyst inference
Evidence
- Original source link unavailable